brequinar has been researched along with mycophenolic acid in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (90.91) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Lemster, B; Starzl, TE; Strednak, J; Thomson, AW; Todo, S; Wang, SC; Woo, J | 1 |
| Morris, RE | 1 |
| Aversa, G; Chang, CC; de Vries, JE; Punnonen, J; Yssel, H | 1 |
| Surdacka, E; Surdacki, A; Sułowicz, W | 1 |
| Demetris, AJ; Miyazawa, H; Murase, N; Nakamura, K; Starzl, TE; Tanabe, M; Valdivia, LA | 1 |
| Duquesnoy, RJ; Fung, JJ; Starzl, TE; Todo, S; Venkataramanan, R; Yao, GZ; Zeevi, A | 1 |
| Cramer, D; Demetris, AJ; Makowka, L; Murase, N; Starzl, TE; Tanabe, M; Valdivia, L | 1 |
| Bumgardner, GL; Roberts, JP | 1 |
| Ericzon, BG; Gannedahl, G; Groth, CG; Ohlman, S | 1 |
| Bach, FH; Blakely, ML; Dalmasso, AP; Van der Werf, WJ | 1 |
| Fujino, Y; Hullett, DA; Kawamura, T; Sollinger, HW | 1 |
| Allison, AM; Fujino, Y; Hullett, DA; Kawamura, T; Sollinger, HW | 1 |
| Allison, AC; Bechstein, WO; Hullett, DA; Kennedy, E; Kowalski, J; Smith, LS; Sollinger, HW; Steele, DM | 1 |
| Allison, AM; Bechstein, WO; Hullett, DA; Kawamura, T; Sollinger, HW; Suzuki, Y | 1 |
| Hullett, DA; Sollinger, HW | 1 |
| Allison, AC; Eugui, EM; Kowalski, WJ; Muller, CJ; Waters, RV | 1 |
| Halloran, PF | 1 |
| Antoniou, EA; Chondros, K; D'Silva, M; Howie, A; McMaster, P; Xu, M | 1 |
| Jaffee, BD; Pally, C; Schuurman, HJ; Tanner, M | 1 |
| Albert, R; Andersen, E; Floersheim, P; Hungerford, V; Papageorgiou, C; Schreier, MH; Zurini, M | 1 |
| Allison, A; Bechstein, WO; Hullett, DA; Jaffee, B; Kawamura, T; Sollinger, HW; Suzuki, Y | 1 |
| Blasco, R; Chiem, K; de la Torre, JC; Gupta, YK; Lorenzo, M; Martínez-Sobrido, L; Morales Vasquez, D; Nogales, A; Xiang, Y | 1 |
7 review(s) available for brequinar and mycophenolic acid
| Article | Year |
|---|---|
Immunopharmacology of new xenobiotic immunosuppressive molecules.
Topics: Animals; Biphenyl Compounds; Cyclosporine; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Mycophenolic Acid; Polyenes; Ribonucleosides; Sirolimus; Tacrolimus; Xenobiotics | 1992 |
[New immunosuppressive drugs in transplantation].
Topics: Biphenyl Compounds; Cyclosporine; Guanidines; Humans; Immunosuppressive Agents; Mycophenolic Acid; Polyenes; Ribonucleosides; Sirolimus; Spiro Compounds; Tacrolimus; Transplantation Immunology | 1994 |
New immunosuppressive agents.
Topics: Alprostadil; Animals; Antibodies, Monoclonal; Biphenyl Compounds; Child; Disease Models, Animal; Dogs; Guanidines; Humans; Immunosuppressive Agents; Liver Transplantation; Mycophenolic Acid; Polyenes; Rats; Sirolimus; Tacrolimus | 1993 |
New immunosuppressive drugs in transplantation.
Topics: Biphenyl Compounds; Cyclosporins; Guanidines; Humans; Immunosuppressive Agents; Kidney; Mycophenolic Acid; Polyenes; Sirolimus; T-Lymphocytes; Tacrolimus; Transplantation Immunology | 1993 |
Mycophenolate mofetil and brequinar sodium: new immunosuppressive agents.
Topics: Animals; Biphenyl Compounds; Graft Survival; Humans; Immunosuppressive Agents; Lymphocyte Activation; Mycophenolic Acid | 1993 |
Mycophenolic acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosylation of adhesion molecules.
Topics: Antimetabolites; Biphenyl Compounds; Cell Adhesion Molecules; Glycosylation; Humans; Mycophenolic Acid; Purines; Pyrimidines | 1993 |
Molecular mechanisms of new immunosuppressants.
Topics: Amino Acid Isomerases; B-Lymphocytes; Biphenyl Compounds; Calcineurin; Calmodulin-Binding Proteins; Carrier Proteins; Cyclosporine; Enzyme Inhibitors; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Isoxazoles; Leflunomide; Mycophenolic Acid; Oxidoreductases; Peptidylprolyl Isomerase; Phosphoprotein Phosphatases; Polyenes; Purines; Pyrimidines; Receptors, Cytokine; Ribonucleosides; Signal Transduction; Sirolimus; T-Lymphocytes; Tacrolimus | 1996 |
15 other study(ies) available for brequinar and mycophenolic acid
| Article | Year |
|---|---|
Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium.
Topics: Animals; B-Lymphocytes; Biphenyl Compounds; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression Regulation; Immunosuppressive Agents; Interleukin-10; Interleukin-2; Lymphocyte Activation; Mice; Mycophenolic Acid; Polymerase Chain Reaction; Ribonucleosides; Tacrolimus | 1992 |
Brequinar sodium, mycophenolic acid, and cyclosporin A inhibit different stages of IL-4- or IL-13-induced human IgG4 and IgE production in vitro.
Topics: Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Biphenyl Compounds; CD40 Antigens; Cells, Cultured; Cyclosporine; Cytokines; Humans; Immunoglobulin E; Immunoglobulin G; Immunosuppressive Agents; Interleukin-13; Interleukin-4; Interleukins; Lymphocyte Activation; Mycophenolic Acid | 1993 |
Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat.
Topics: Animals; Antibodies; Antineoplastic Agents; Azathioprine; Biphenyl Compounds; Cricetinae; Cyclophosphamide; Graft Survival; Guanidines; Heart Transplantation; Immunosuppressive Agents; Liver Transplantation; Male; Mesocricetus; Methotrexate; Mycophenolic Acid; Rats; Rats, Inbred Lew; Ribonucleosides; Tacrolimus; Transplantation, Heterologous | 1993 |
Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors.
Topics: Aspartic Acid; Biphenyl Compounds; Calcimycin; Cells, Cultured; Cyclosporine; Humans; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; Lymphocytes; Mycophenolic Acid; Phosphonoacetic Acid; Ribonucleosides; T-Lymphocytes; Tacrolimus; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1993 |
Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs.
Topics: Animals; Antibody Formation; Antilymphocyte Serum; Biphenyl Compounds; Cricetinae; Cyclophosphamide; Drug Synergism; Drug Therapy, Combination; Fluorescent Antibody Technique; Follow-Up Studies; Graft Rejection; Graft Survival; Heart Transplantation; Immunoglobulin A; Immunoglobulin M; Immunosuppressive Agents; Liver Transplantation; Male; Mesocricetus; Mycophenolic Acid; Rats; Splenectomy; Tacrolimus; Transplantation, Heterologous | 1993 |
Anti-B cell agents: suppression of natural antibodies and prolongation of survival in discordant xenografts.
Topics: Animals; Antibodies, Heterophile; Antibody Formation; B-Lymphocytes; Biphenyl Compounds; Cyclosporine; Graft Survival; Guinea Pigs; Immunosuppression Therapy; Immunosuppressive Agents; Mycophenolic Acid; Polyenes; Rats; Rats, Inbred Lew; Sirolimus; Splenectomy; Time Factors; Transplantation, Heterologous | 1994 |
Evaluation of cyclosporine, mycophenolate mofetil, and Brequinar sodium combination therapy on hamster-to-rat cardiac xenotransplantation.
Topics: Animals; Antibody Formation; Biphenyl Compounds; Cricetinae; Cyclosporine; Cytotoxicity, Immunologic; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppression Therapy; Male; Mesocricetus; Mycophenolic Acid; Rats; Rats, Inbred Lew; Transplantation, Heterologous | 1994 |
Prolongation of allograft and xenograft survival with mycophenolate mofetil (RS-61443) and brequinar sodium (DUP-785).
Topics: Animals; Biphenyl Compounds; Cricetinae; Graft Survival; Guinea Pigs; Heart Transplantation; Immunosuppressive Agents; Male; Mesocricetus; Mycophenolic Acid; Rats; Rats, Inbred Lew; Time Factors; Transplantation, Heterologous; Transplantation, Heterotopic; Transplantation, Homologous | 1993 |
Effects of immunosuppressive therapy on the rat aortic allograft model.
Topics: Animals; Aorta; Biphenyl Compounds; Cell Division; Cyclosporine; Immunosuppressive Agents; Male; Muscle, Smooth, Vascular; Mycophenolic Acid; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic | 1993 |
Enhancement of allograft survival by combination RS-61443 and DUP-785 therapy.
Topics: Animals; Biphenyl Compounds; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Mycophenolic Acid; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Transplantation, Homologous | 1993 |
Combination treatment effectively intercepts advanced acute cardiac rejection.
Topics: Animals; Biphenyl Compounds; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Mycophenolic Acid; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Transplantation, Homologous; Transplantation, Isogeneic | 1997 |
Brequinar and brequinar analogues in rat allo- and xenotransplantation.
Topics: Animals; Biphenyl Compounds; Cricetinae; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Mesocricetus; Mycophenolic Acid; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Structure-Activity Relationship; Transplantation, Heterologous; Transplantation, Homologous | 1998 |
Inhibition of cyclosporin-resistant B-cell antigen responses by pyrazoles: a tool for the identification of novel molecular mechanisms of B-cell activation.
Topics: Aniline Compounds; Animals; Antigens, Heterophile; B-Lymphocytes; Biphenyl Compounds; Cell Division; Crotonates; Cyclosporine; Drug Resistance; Graft Rejection; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Lymphoma, B-Cell; Mycophenolic Acid; Nitriles; Primates; Pyrazoles; Swine; T-Lymphocytes; Toluidines; Transplantation, Heterologous; Tumor Cells, Cultured | 2001 |
Low-dose combination therapy of DUP-785 and RS-61443 prolongs cardiac allograft survival in rats.
Topics: Animals; Biphenyl Compounds; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Models, Animal; Mycophenolic Acid; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic | 1992 |
Identification of
Topics: Antimycin A; Antiviral Agents; Humans; Monensin; Monkeypox virus; Mpox (monkeypox); Mycophenolic Acid; Rotenone; Smallpox; Valinomycin | 2023 |